In addition, patients with lymph node metastasis had higher serum exosomal HOTAIR expressions than those with no metastases, suggesting that circulating HOTAIR could be a valuable biomarker to screen and predict progression for LSCC patient [141]. This evidence concerns the gene HOTAIR and metastatic malignant neoplasm in the lymph nodes.